b 927 5
Generic Name: methotrexate
Pill imprint b 927 5 has been identified as Trexall 5 mg.
Trexall is used in the treatment of psoriasis; rheumatoid arthritis; brain tumor; breast cancer; ectopic pregnancy (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy.
Trexall 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Trexall Images
- Generic Name:
- methotrexate
- Imprint:
-
b
927 5 - Strength:
- 5 mg
- Color:
- Green
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
Advertisement
More Trexall resources
Trexall is associated with the treatment of:
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia
- Acute Nonlymphocytic Leukemia
- Bladder Cancer
- Brain Tumor
- Breast Cancer
- Bullous Pemphigoid
- Cervical Cancer
- Choriocarcinoma
- Cogan's Syndrome
- Colorectal Cancer
- Dermatomyositis
- Ectopic Pregnancy
- Eczema
- Esophageal Carcinoma
- Gastric Cancer
- Graft-versus-host disease
- Head and Neck Cancer
- Hodgkin's Lymphoma
- Lymphoma
- Meningeal Leukemia
- Mycosis Fungoides
- Neoplastic Diseases
- Non-Hodgkin's Lymphoma
- Non-Small Cell Lung Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancreatic Cancer
- Pemphigoid
- Pemphigus
- Psoriasis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Small Cell Lung Cancer
- Soft Tissue Sarcoma
- Solid Tumors
- Systemic Sclerosis
- Trophoblastic Disease
- Uveitis
Search Again
